ERK inhibitor III   Click here for help

GtoPdb Ligand ID: 5968

Compound class: Synthetic organic
Comment: This is compound 89 in [2] where it is described as an ATP-independent inhibitor of ERK1/2, which blocks substrate binding.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 162.19
Molecular weight 318.07
XLogP 3.54
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES [O-][N+](=O)NC(=NN=Cc1ccc(o1)c1cccc(c1)[N+](=O)[O-])N
Isomeric SMILES [O-][N+](=O)N/C(=N/N=C\c1ccc(o1)c1cccc(c1)[N+](=O)[O-])/N
InChI InChI=1S/C12H10N6O5/c13-12(16-18(21)22)15-14-7-10-4-5-11(23-10)8-2-1-3-9(6-8)17(19)20/h1-7H,(H3,13,15,16)/b14-7-
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Chen F, Hancock CN, Macias AT, Joh J, Still K, Zhong S, MacKerell Jr AD, Shapiro P. (2006)
Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure.
Bioorg Med Chem Lett, 16 (24): 6281-7. [PMID:17000106]
3. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013)
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Biochem J, 451 (2): 313-28. [PMID:23398362]